HCV-IN-38
HCV-IN-38 is a potent, selective and orally active HCV inhibitor (EC50=15 nM, SI=431) . HCV-IN-38 has high anti-HCV activity and low cytotoxicity. HCV-IN-38 has a good safety and oral pharmacokinetic profile[1].
Product Specifications
CAS Number
3035807-39-4
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-38.html
Solubility
10 mM in DMSO
Smiles
CN(C1CN(C1)CC2=CC=C(C=C2C(F)(F)F)NC(C3=CC=C(C([N+]([O-])=O)=C3)OCCCl)=O)C
Molecular Formula
C22H24ClF3N4O4
Molecular Weight
500.90
References & Citations
[1]Liu Y, et al. Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus. Eur J Med Chem. 2022;228:114033.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL504695V 500 µL Each
Ccdc71l Mouse shRNA Lentiviral Particle (Locus ID 72123)
Sign In for Pricing
View Details 
223006-01 50 µL
Gp130 (Interleukin-6 Receptor Subunit beta, IL-6 Receptor Subunit beta, IL-6R Subunit beta, IL-6R-beta, IL-6RB, CDw130, Interleukin-6 Signal Transducer, Membrane Glycoprotein 130, gp130, Oncostatin-M Receptor Subunit alpha, CD130, IL6ST) discontinued
Sign In for Pricing
View Details 223006-02 100 µL
Gp130 (Interleukin-6 Receptor Subunit beta, IL-6 Receptor Subunit beta, IL-6R Subunit beta, IL-6R-beta, IL-6RB, CDw130, Interleukin-6 Signal Transducer, Membrane Glycoprotein 130, gp130, Oncostatin-M Receptor Subunit alpha, CD130, IL6ST) discontinued
Sign In for Pricing
View Details ARP69409_P050-HRP 100 µL
C8orf42 Antibody - N-terminal region : HRP (ARP69409_P050-HRP)
Sign In for Pricing
View Details 